FDA Approves First Biosimilar to Treat Multiple Sclerosis

[FDA]

FDA has approved the first biosimilar to Tysabri (natalizumab) injection for the treatment of relapsing forms of multiple sclerosis.


Baca selengkapnya di : http://www.fda.gov...